BIOPOLYMER ENGINEERING INC has a total of 23 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, macromolecular chemistry and polymers and environmental technology are UNIHART CORP, BARROS RES INST and PHASEBIO PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | China | 4 | |
#4 | Australia | 3 | |
#5 | United States | 3 | |
#6 | Republic of Korea | 2 | |
#7 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Macromolecular chemistry and polymers | |
#3 | Environmental technology | |
#4 | Biotechnology | |
#5 | Foods and drinks | |
#6 | Machines | |
#7 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Polysaccharides | |
#4 | Climate change adaptation technologies | |
#5 | Peptides | |
#6 | Unspecified technologies | |
#7 | Macromolecular compounds compositions | |
#8 | Food shaping | |
#9 | Special foods | |
#10 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Ostroff Gary R | 14 |
#2 | Ross Gordon D | 7 |
#3 | Karel Steven J | 3 |
#4 | Jamas Spiros | 2 |
#5 | Patchen Myra L | 2 |
#6 | Easson Jr D Davidson | 2 |
#7 | Cox Donald | 1 |
#8 | Ross Trunetta Jo Dockter | 1 |
#9 | Cox Donald J | 1 |
#10 | Talbot Steven | 1 |
Publication | Filing date | Title |
---|---|---|
KR20100029193A | Particulate-soluble glucan preparation | |
WO2006119395A2 | Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection | |
CN1964722A | Whole glucan particles in combination with antibiotics, vaccines and viral monoclonal antibodies | |
AU2003295326A8 | Cancer therapy using beta glucan and antibodies | |
AU2003258181A1 | Methods of using beta glucan as a radioprotective agent | |
US7786094B2 | Use of beta-glucans against biological warfare weapons and pathogens including anthrax |